In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
- TRADE NAME: Serzone (Bristol-Myers Squibb)
- INDICATIONS: Depression
- CLASS: Antidepressant, CYP3A4 inhibitor, Norepinephrine reuptake inhibitor
- HALF-LIFE: 2–4 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abiraterone, Aprepitant, Astemizole, Atorvastatin, Avanafil, Buspirone, Cabozantinib, Calcifediol, Ceritinib, Copanlisib, Crizotinib, Darunavir, Dasatinib, Dronedarone, Eletriptan, Erlotinib, Eszopiclone, Fesoterodine, Flibanserin, Fluticasone Propionate, Indinavir, Isocarboxazid, Ivabradine, Ixabepilone, Lapatinib, Lomitapide, Lumateperone, MAO inhibitors, Methylergonovine, Midostaurin, Mifepristone, Neratinib, Olaparib, Osimertinib, Paclitaxel, Palbociclib, Phenelzine, Pimozide, Ponatinib, Rimonabant, Romidepsin, Ruxolitinib, Selegiline, Sibutramine, Simvastatin, Solifenacin, Sonidegib, St John's Wort, Sumatriptan, Sunitinib, Temsirolimus, Ticagrelor, Tipranavir, Tolvaptan, Tramadol, Tranylcypromine, Trazodone, Ulipristal, Vemurafenib, Vorapaxar
- See adverse reactions attributed to class:
SUICIDALITY AND ANTIDEPRESSANT DRUGS and HEPATOTOXICITY
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
